Rybelsus 14mg is the maximum therapeutic maintenance dose of Semaglutide, an oral glucagon-like peptide-1 (GLP-1) receptor agonist. This medication provides physiological support for long-term glycemic management in adults with type 2 diabetes by maximizing glucose-dependent insulin secretion, inhibiting glucagon release, and regulating gastric emptying to lower HbA1c levels.

Dosage & Administration

• 1 tablet per day.
• Administer orally on an empty stomach immediately upon waking.
• Liquid limit: Administer with no more than 120ml (4 ounces) of plain water.
• Wait period: Do not consume food, other beverages, or other oral medications for at least 30 minutes after administration. Failure to wait reduces the absorption of the active ingredient.
• Swallow whole: Do not crush, split, or chew the tablets. The tablet must remain intact for the SNAC (sodium salcaprozate) delivery system to function within the stomach.

Safety & Storage

• Adverse Reactions: Common gastrointestinal effects include nausea, diarrhea, vomiting, and constipation. These may be more pronounced at the 14mg dosage level.
• Storage: Store tablets in the original blister card until use to protect from moisture. Maintain at controlled room temperature below 30°C.